MINNEAPOLIS–(BUSINESS WIRE)– DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders, today announced that Rick Pauls, its President and CEO will be participating at Lake Street Capital Marketâs 7th Annual Best Ideas Growth (BIG7) Conference in New York, on September 14, 2023.…Read More
DiaMedica Therapeutics to Participate at Lake Streets 7th Annual Best Ideas Growth Conference
